The definition of acute-on-chronic liver failure (ACLF) remains contested. In Europe and
North America, the term is generally applied according to the European Association for the …

Model for end-stage liver disease (MELD) score, initially developed to predict survival
following transjugular intrahepatic portosystemic shunt was subsequently found to be …

Background The results of liver transplantation are excellent, with survival rates of over 90
and 80% at 1 and 5 years, respectively. The success of liver transplantation has led to an …

Patients listed for liver transplantation (LT) as status 1a currently receive the highest priority
on the waiting list. The presence of acute on chronic liver failure (ACLF) with three or more …

The clinical stages of cirrhosis have traditionally been divided into a compensated phase
with no complications and a decompensated phase that manifests with complications of …

Purpose Acute liver failure (ALF) and acute on chronic liver failure (ACLF) are associated
with significant mortality and morbidity. Extracorporeal liver support (ECLS) devices have …

Over the past 2 decades, the concept of acute-on-chronic liver failure (ACLF) has been
proposed as an alternate path in the natural history of decompensated cirrhosis. ACLF thus …

The liver transplant allocation system is currently based upon the Model for End-Stage Liver
Disease (MELD) score and allocates organs preferentially to patients with the highest scores …

In a context of global organ shortage, the Model for End-Stage Liver Disease (MELD) score
seems to be a fair prioritization tool, with a paradigm:“sickest first.” Since its introduction in …

Since the adoption of the model for end-stage liver disease (MELD) score for organ
allocation in 2002, numerous changes to the system of liver allocation and distribution have …